CN115551484A - 一种法匹拉韦组合物及其制备方法 - Google Patents
一种法匹拉韦组合物及其制备方法 Download PDFInfo
- Publication number
- CN115551484A CN115551484A CN202080100612.1A CN202080100612A CN115551484A CN 115551484 A CN115551484 A CN 115551484A CN 202080100612 A CN202080100612 A CN 202080100612A CN 115551484 A CN115551484 A CN 115551484A
- Authority
- CN
- China
- Prior art keywords
- composition
- favipiravir
- percent
- weight
- povidone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种法匹拉韦组合物、法匹拉韦片剂及其制备方法，组合物包含法匹拉韦或其盐、占组合物重量百分比为2.5％‑15％的崩解剂羧甲基淀粉钠或羧甲基纤维素钙中的一种或两种组合和粘合剂。法匹拉韦组合物药物含量高，可实现法匹拉韦的快速释放，在体外溶出试验中能够在15分钟溶出≥85％。
Description
PCT国内申请，说明书已公开。
Claims (13)
- PCT国内申请，权利要求书已公开。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010565808 | 2020-06-19 | ||
| CN202010565808X | 2020-06-19 | ||
| PCT/CN2020/118723 WO2021253681A1 (zh) | 2020-06-19 | 2020-09-29 | 一种法匹拉韦组合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115551484A true CN115551484A (zh) | 2022-12-30 |
Family
ID=79269111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080100612.1A Pending CN115551484A (zh) | 2020-06-19 | 2020-09-29 | 一种法匹拉韦组合物及其制备方法 |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN115551484A (zh) |
| WO (1) | WO2021253681A1 (zh) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011009440A (es) * | 2009-03-13 | 2011-11-04 | Toyama Chemical Co Ltd | Tableta y polvo granulado que contiene 6-fluoro-3-hidroxi-2-pirazi ncarboxamida. |
| CN106667926B (zh) * | 2015-11-09 | 2020-01-17 | 石药集团中奇制药技术（石家庄）有限公司 | 一种法匹拉韦片剂及其制备方法 |
| CN105687152B (zh) * | 2016-03-22 | 2020-04-07 | 山东齐都药业有限公司 | 一种法匹拉韦快速释放药物制剂及制备方法 |
-
2020
- 2020-09-29 CN CN202080100612.1A patent/CN115551484A/zh active Pending
- 2020-09-29 WO PCT/CN2020/118723 patent/WO2021253681A1/zh active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021253681A1 (zh) | 2021-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100384215B1 (ko) | 방출지속성다분산하디로겔시스템-비정질약물 | |
| US20090324717A1 (en) | Extended release pharmaceutical formulation of metoprolol and process for its preparation | |
| WO2022012172A1 (zh) | 一种难溶性药物口服缓释组合物及其制备方法 | |
| US20030224045A1 (en) | Combination immediate release sustained release levodopa/carbidopa dosage forms | |
| JP5417662B2 (ja) | ネビラピンの徐放性製剤 | |
| CN112933061B (zh) | 一种盐酸阿比多尔胶囊及其制备方法 | |
| JP2017190325A (ja) | 化学的な安定性を改善した、非晶質体ソリフェナシン含有製剤 | |
| US20090155369A1 (en) | Pharmaceutical composition containing levodopa, entacapone and carbidopa | |
| CN111297823B (zh) | 一种磷酸奥司他韦胶囊的制备方法 | |
| JP2009519313A (ja) | 医薬組成物 | |
| CN109745295B (zh) | 利伐沙班口服固体制剂及其制备方法 | |
| CN114917233B (zh) | 一种包含核苷类似物的药物组合物及其制备方法和应用 | |
| CN109125270B (zh) | 一种固体制剂及其制备方法 | |
| WO2020021110A1 (en) | Pharmaceutical composition of ticagrelor | |
| CN115551484A (zh) | 一种法匹拉韦组合物及其制备方法 | |
| CN108066304B (zh) | 具有缓释性能的坦索罗辛口腔崩解片组合物 | |
| CN110251476B (zh) | 一种恩曲他滨替诺福韦药物组合物 | |
| WO2002034268A1 (fr) | Preparation a liberation prolongee contenant comme principe actif du trihydrochlorure de 5-acetyl-4,6-dimethyl-2-(2-(4-(2-methoxyphenyl)piperazinyl)ethylamino)pyrimidine | |
| WO2020122244A1 (ja) | 錠剤及びその製造方法 | |
| EP3761965A1 (en) | Ticagrelor-containing tablet formulation | |
| CN106474084B (zh) | 一种盐酸普拉克索缓释制剂及其制备方法 | |
| CN114344306B (zh) | 含苯基嘧啶酮盐酸盐的药物组合物，包含其的药物制剂，及其制备方法和用途 | |
| WO2022042646A1 (zh) | 盐酸鲁拉西酮组合物及其制备方法 | |
| CN113694052B (zh) | 一种含有对乙酰氨基酚和盐酸曲马多的包衣片剂 | |
| JP5563371B2 (ja) | クエチアピンフマル酸塩含有経口用錠剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |